Diabetes drug promotes longevity by stimulating the body’s production of ether lipids

Metformin, the most commonly used drug to treat type 2 diabetes, not only lowers blood sugar levels but has revealed to extend lifespan in C. Elegans — an animal model that shares similar metabolic systems with humans and are often used to model human diseases.

European regulator says evidence shows no thyroid cancer link to GLP-1s

Current evidence doesn’t support a link between GLP-1 receptor agonists and thyroid cancer, Europe’s drug regulator announced Friday following safety concerns that have been raised

October 28, 2023

Study uses cellulose sheets to map body’s extracellular vesicles, unlocking disease insights

Study demonstrates the use of cellulose nanofiber sheets for spatial analysis of extracellular vesicles, revealing their geographical heterogeneity in the human body, which could advance

November 14, 2023

From Cobenfy to Emraclidine: the muscarinic path to safer antipsychotics

On 26 September 2024, Cobenfy (KarXT) gained US Food and Drug Administration (FDA) approval as the first novel class of antipsychotics in decades. Developed by

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.